|
Symbol Name ID |
Agt
angiotensinogen MGI:87963 |
Excel File
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Agttm1Afu/Agttm1Afu Tg(Fabp4-Agt)1Mte/0 involves: C57BL/6 * CBA * DBA/2 * ICR |
hypertension | J:73163 |
| Agttm1Afu/Agttm1Afu Tg(Fabp4-Agt)2Mte/0 involves: C57BL/6 * CBA * DBA/2 * ICR |
decreased circulating angiotensinogen level | J:73163 |
| Agttm1Unc/Agttm2Unc involves: 129P2/OlaHsd * C57BL/6J |
normal cardiovascular system phenotype | J:24156 |
| decreased circulating angiotensinogen level | J:24156 | |
| normal renal/urinary system phenotype | J:24156 | |
| Agttm2Unc/Agt+ involves: 129P2/OlaHsd * C57BL/6J |
decreased superovulation rate | J:69609 |
| increased circulating angiotensinogen level | J:18272, J:24156 | |
| increased systemic arterial blood pressure | J:24156 | |
| normal renal/urinary system phenotype | J:24156 | |
| Agttm2Unc/Agttm2Unc involves: 129P2/OlaHsd * C57BL/6J |
decreased superovulation rate | J:69609 |
| increased circulating angiotensinogen level | J:24156 | |
| increased systemic arterial blood pressure | J:24156 | |
| normal renal/urinary system phenotype | J:24156 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/16/2024 MGI 6.23 |
|
|
|
||
Analysis Tools